Stavudine

司他夫定

Report date: 2022/12/07 17:15:43
NME

Base Information

Drug NameStavudine
Drug Alias Nameestavudina双脱氧胸苷Zeritavir司它夫定Sanilvudine +[12] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionHuman immunodeficiency virus type 1 reverse transcriptase inhibitors
TargetsHuman immunodeficiency virus type 1 reverse transcriptase
Therapy Area/IndicationsAIDS Dementia ComplexHIV Infections
Global Approved IndicationsHIV Infections
Approved Indications in ChinaHIV Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1994/06/24
Country/TerritoryUnited StatesAustraliaUnited Kingdom +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesNortheast Pharmaceutical Group Co Ltd
Inactive CompaniesBristol Myers Squibb SrlcompanyBristol-Myers Squibb Pharma EeigBristol-Myers Squibb Company +[4] 
Active IndicationsHIV Infections
Inactive IndicationsAIDS Dementia Complex

Other Information

ATC CodeJ05AF04
Related LinksWikipediaDrugBankKEGG